Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Imatinib-Mesylate Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Imatinib Mesylate Manufacturers in India Suppliers Imatinib Mesylate Exporters Distributors Imatinib Mesylate api active pharmaceuticals ingredients Imatinib Mesylate manufacturers Side Effects bulk drugs raw material Imatinib Mesylate companies Side Effects Importers Imatinib Mesylate Imatinib Mesylate Exporters Imatinib Mesylate exporters FDA Imatinib Mesylate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Imatinib Mesylate manufacturing pharmaceutical drugs pharmaceutical intermediates Imatinib Mesylate pharmaceutical chemicals pharmaceutical raw materials Imatinib Mesylate active pharmaceutical ingredients Imatinib Mesylate committee active pharmaceutical ingredients manufacturer Imatinib Mesylate Active Pharmaceutical Ingredients manufacturer Imatinib Mesylate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Imatinib Mesylate, Imatinib Mesylate manufacturer India, Imatinib Mesylate product, Imatinib Mesylate products, Api preparation, Certificate of Analysis API manufacturer product, Imatinib Mesylate anti ulcer product, Certificate of Origin COA Imatinib Mesylate COS Imatinib Mesylate, pharmaceutical generic, pharmaceutical drug, medical, Imatinib Mesylate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Imatinib Mesylate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Imatinib Mesylate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Imatinib Mesylate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Imatinib Mesylate ingredients, api, HIV Imatinib Mesylate, tablets, capsules, syrup & protein Imatinib Mesylate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Imatinib Mesylate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Imatinib Mesylate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

pharma Imatinib Mesylate

 






 









 

 

HOME >> API >> API List 2 >> Imatinib Mesylate >> Precautions

matinib Mesylate CAS Registry Number 220127-57-1

PRECAUTIONS
Imatinib Mesylate

Before taking imatinib, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: bleeding problems, heart problems (e.g., heart failure), kidney problems, liver problems.

Do not have immunizations/vaccinations without the consent of your doctor, and avoid contact with people who have recently received oral polio vaccine or flu vaccine inhaled through the nose. Wash your hands well to prevent the spread of infections.

To lower your risk of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports.

Before having surgery, tell your doctor or dentist that you are using this medication.

The elderly may be more sensitive to the side effects of this drug (e.g., swelling). Also, the manufacturer recommends a routine heart test in the elderly before treatment.

This medication is not recommended for use during pregnancy. It may harm the unborn baby. If you become pregnant or think you may be pregnant, inform your doctor immediately. To avoid pregnancy, both males and females using this drug must use reliable form(s) of birth control (e.g., condoms, birth control pills) during treatment with this drug. Talk with your doctor about effective forms of birth control.

It is not known whether this drug passes into breast milk. Because of the potential risk to the infant, breast-feeding while using this drug is not recommended. Consult your doctor before breast-feeding.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS >>
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo
 

Imatinib Mesylate

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.